Galapagos NV DPO Ratio 2011-2026 | GLPG

Annual DPO Ratio Galapagos NV

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	81.9	98.6	260	167	-

All numbers in EUR currency

Maximum	Minimum	Average
260	81.9	152

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	31.7	$ 19.55	0.1 %	$ 914 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Arena Pharmaceuticals ARNA	142	-	-6.81 %	$ 3.04 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	182	-	-	$ 546 M	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Avid Bioservices CDMO	62.3	-	-	$ 789 M	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
Enlivex Therapeutics Ltd. ENLV	193	$ 1.07	-1.83 %	$ 21.9 M	Israel
Eton Pharmaceuticals ETON	74.3	$ 23.73	1.17 %	$ 639 M	USA
Arbutus Biopharma Corporation ABUS	23	$ 4.44	-0.22 %	$ 851 M	Canada
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA